<DOC>
	<DOCNO>NCT00261365</DOCNO>
	<brief_summary>The purpose study identify candidate marker predictive response and/or serious toxicity BMS-734016 ( MDX-010 ) .</brief_summary>
	<brief_title>Phase II Study Determine Predictive Markers Response BMS-734016 ( MDX-010 )</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Histologic cytologic diagnosis unresectable State III IV malignant melanoma ( exclude ocular melanoma ) ; A pre posttreatment fresh core excision tumor biopsy must provide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>